Gyre Therapeutics (GYRE) Net Equity Issued and Repurchased (2010 - 2026)
Gyre Therapeutics (GYRE) posted quarterly Net Equity Issued and Repurchased of $500000.0 for Q1 2026, down 1.77% year-over-year from $509000.0 in Q1 2025, and up 102.13% quarter-over-quarter from -$23.5 million in Q4 2025.
Gyre Therapeutics (GYRE) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Net Equity Issued and Repurchased for 12 consecutive years, with $500000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased fell 1.77% year-over-year to $500000.0; the TTM figure through Mar 2026 stood at $1.3 million (down 97.45% YoY), while the FY2025 annual figure was $1.3 million, up 60.0% from the prior year.
- Net Equity Issued and Repurchased climbed to $500000.0 in Q1 2026 per GYRE's latest filing, from -$23.5 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $23.0 million in Q2 2025 and bottomed at -$23.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | -23.51 Mn |
| Dec 31, 2025 | -23.51 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 23.00 Mn |
| Jun 30, 2025 | 23.00 Mn |
| Mar 31, 2025 | 509,000.00 |
| Mar 31, 2025 | 509,000.00 |
| Mar 31, 2021 | 49.30 Mn |
| Mar 31, 2021 | 49.30 Mn |
| Jun 30, 2018 | 1,000.00 |
| Jun 30, 2018 | 1,000.00 |
| Mar 31, 2018 | 106.76 Mn |
| Mar 31, 2018 | 106.76 Mn |
| Jun 30, 2017 | -13.26 Mn |
| Jun 30, 2017 | -13.26 Mn |
| Mar 31, 2017 | 1.78 Mn |
| Mar 31, 2017 | 1.78 Mn |